Mounjaro® and taste changes

Three documents, one rare reaction

The US label reports dysgeusia in a short paragraph of section 6.1 rather than in its main table, which only lists reactions seen in at least 5% of people. The figure comes from the pool of SURPASS-1 and SURPASS-5, in which 718 adults with type 2 diabetes took tirzepatide for an average of 36.6 weeks ^[1]. Canada, whose main table starts at 1%, places dysgeusia in a separate list of less common trial reactions, and its patient information names “change in taste” among possible side effects ^[4]. Europe uses frequency bands across all its tirzepatide trials and puts dysgeusia in the uncommon one ^[3].

Reading a figure of 0.1%

A rate of 0.1% means about one person in a thousand. In a pool of 718 people that is roughly one report, so the label is telling you the reaction was seen and was not seen on placebo, not giving a precise risk ^[1]. The European band, uncommon, covers anything from 1 in 1,000 to 1 in 100 and draws on many more trials, including weight-management studies ^[3].

The same molecule sold as Zepbound® for weight reduction shows a somewhat higher figure, 0.4%, in its obesity trials ^[5]. Those trials enrolled different people on a different background, so the two numbers describe different groups rather than a difference between the products. Neither label says when a taste change starts, how long it lasts or whether it depends on the dose.

What research outside the trials shows

No study has been designed to measure taste on tirzepatide. A 2025 analysis of the US FDA Adverse Event Reporting System covering six GLP-1 medicines, tirzepatide among them, found dysgeusia, taste disorder and parosmia, a distorted sense of smell, among nervous-system signals for the class, with many reports in the first month ^[6]. Another analysis of the same database, focused on ear, nose and throat effects, reported significant dysgeusia signals for semaglutide, liraglutide and exenatide; its summary does not report one for tirzepatide ^[7].

A 2026 overview of oral and salivary effects of these medicines, including tirzepatide, lists taste disturbance alongside dry mouth, reduced saliva and burning sensations, and stresses that the evidence comes largely from case reports and report databases ^[8]. Report databases show what people chose to report, not how often something happens, and they cannot prove the medicine was the cause ^[6][8].

Possible explanations, by certainty

• Established in the label: a change in taste occurs on tirzepatide, rarely, and more often than on placebo ^[1][3]. The label offers no mechanism.
• Proposed by researchers: effects on the salivary glands and their nerve supply, and dehydration from vomiting or diarrhea, could reduce saliva and alter taste ^[8]. Mouth dryness is a recognised cause of impaired taste ^[9]. These ideas have not been tested for tirzepatide.
• General knowledge: much of what people call taste is really smell. Aromas released while chewing travel to the nose from the back of the throat, so a blocked nose makes food seem bland ^[10]. A distorted taste that lingers, described as foul, salty, rancid or metallic, is what doctors call dysgeusia ^[10].

Causes worth ruling out

Many people on Mounjaro® also take metformin. MedlinePlus lists a change in the sense of taste among metformin’s possible side effects, along with stomach upset ^[11]. If both medicines started around the same time, either could be involved, and only your prescriber can sort that out.

MedlinePlus also lists colds, flu, sinus infections and nasal polyps, sore throat, salivary gland infections, gum inflammation, heavy smoking, head or mouth injury, some ear or sinus surgery, low vitamin B12 or zinc, and a range of medicines, including some antibiotics and thyroid medicines ^[9]. Taste often fades after 60, with salt and sweet going first ^[9]. A new toothpaste or mouthwash is one of the questions a doctor may ask about ^[9].

What may help, according to health agencies

The Mounjaro® documents give no advice specific to taste; the Medication Guide asks you to report side effects that bother you or do not go away ^[2]. The NIH and MedlinePlus suggest the following, which apply to taste problems in general.

• Add flavour with aromatic herbs and spices rather than extra sugar or salt, which matters for people with diabetes or high blood pressure ^[10].
• Keep up good oral hygiene, which the NIH links to keeping a well-functioning sense of taste ^[10].
• If you smoke, stopping can help; taste lost to a cold or flu usually returns when the illness passes ^[9].
• Do not stop a prescribed medicine you suspect on your own; changing it is a decision for your doctor ^[10].
• If a taste problem persists, an ear, nose and throat specialist can test taste and smell and look for a cause ^[10].
• Tirzepatide can change how tablets are absorbed, so check with a pharmacist before adding a supplement such as zinc ^[1].

Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. PepLabo is not affiliated with or endorsed by Eli Lilly and Company.